SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-17-003053
Filing Date
2017-04-28
Accepted
2017-04-28 16:08:17
Documents
7
Period of Report
2017-06-20
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2231976zdef14a.htm DEF 14A 350570
2 G197024.JPG g197024.jpg GRAPHIC 19844
3 G1021906.JPG g1021906.jpg GRAPHIC 7951
4 G894954.JPG g894954.jpg GRAPHIC 9297
5 G870491.JPG g870491.jpg GRAPHIC 14717
6 G119042BCI001.GIF g119042bci001.gif GRAPHIC 271010
7 G119042BCI002.GIF g119042bci002.gif GRAPHIC 155962
  Complete submission text file 0001047469-17-003053.txt   1011666
Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37926 | Film No.: 17795506
SIC: 2834 Pharmaceutical Preparations